Table 1.

Demographics and clinical characteristics in the Meth group versus Non-meth group.

Variables	Meth group	Non-meth group	p
n	61	1297	–
Age	54.5 ± 9.7	70.5 ± 12.4	< 0.001
Male (%)	48 (78.7%)	709 (54.0%)	< 0.001
Race
White	48 (78.7%)	654 (50.4%)	< 0.001
Hispanic	6 (9.8%)	231 (17.8%)	0.197
Black	3 (4.9%)	30 (2.3%)	0.213
Asian	2 (3.3%)	312 (24.1%)	< 0.001
Other	2 (3.3%)	70 (5.4%)	0.471
Hypertension	35 (57.4%)	935 (71.4%)	0.013
Diabetes	20 (32.8%)	447 (36.4%)	0.788
Hyperlipidemia	16 (26.2%)	523 (40.0%)	0.028
Obesity	10 (16.4%)	178 (13.6%)	0.555
Smoking	35 (57%)	390 (30.1%)	< 0.001
Cocaine use	7 (11.5%)	9 (0.7%)	< 0.001
Statin use	10 (16%)	525 (40.5%)	< 0.001
Antithrombotic use	14 (23%)	452 (34.8%)	0.056
Initial NIHSS score	4 (2, 10)	4 (2, 14)	0.154
Baseline LDL cholesterol	104 ± 38	99 ± 39	0.213
Mechanism of stroke
Large artery disease	15 (25%)	312 (24.1%)	0.924
Cardioembolism	21 (34%)	592 (45.6%)	0.085
Small vessel disease	19 (31%)	361 (27.8%)	0.573
Other causes	2 (3%)	52 (4%)	0.775

NIHSS National Institutes of Health Stroke Scale, LDL low density lipoprotein cholesterol.

Significant are in value [bold].